Over the last decade somatostatin receptor scintigraphy using various derivatives of long-acting
somatostatin analogues has gained its place in the management of pancreatic islet-cell …

Response Assessment in Neuro-Oncology (RANO) response criteria have been established
and were updated in 2023 for MRI-based response evaluation of diffuse gliomas in clinical …

The present procedural guidelines summarize the current views of the EANM Neuro-Imaging
Committee (NIC). The purpose of these guidelines is to assist nuclear medicine …

Background Intraoperative identification of anaplastic foci in diffusely infiltrating gliomas (DIG)
with non-significant contrast-enhancement on MRI is indispensible to avoid …

Dopamine transporter imaging is widely used for the differential diagnosis of parkinsonism.
Only limited data are available on the relationship between striatal dopamine transporter …

Gliomas are the most common type of tumor in the brain. Although the definite diagnosis is
routinely made ex vivo by histopathologic and molecular examination, diagnostic work-up of …

Primary diffuse leptomeningeal melanomatosis (PDLMM) is an extremely rare and aggressive
cancer type for which best treatment strategies remain to be elucidated. Herein, we …

Lecanemab is a humanized IgG1 monoclonal antibody that targets protofibrils, a species of
soluble aggregated amyloidbeta (Aβ). The drug was approved by the US Food and Drug …

Absolute quantification of PET brain imaging requires the measurement of an arterial input
function (AIF), typically obtained invasively via an arterial cannulation. We present an …

Purpose There is evidence that mild cognitive impairment (MCI) or Alzheimer's disease (AD)
is accompanied by alterations in the retina. The current study was performed to investigate …